This week, www.selectscience.net reported
on 20 news stories the day they happened,
so if you need to keep up to speed on
the latest business developments in
chemistry and life science, make the news
ticker on www.selectscience.net part of
your daily routine.
Andrew Smith (andrew at selectscience.net)
Editor, www.selectscience.net
This week's headlines were:
PE Biosystems Stock To Split Two-For-One
QIAGEN N.V. Annual Report 1998
Neurogen Licenses AIDD(SM) Technology to Pfizer for $27 Million
Bio-Rad Laboratories Announces Its Offer for Pasteur Sanofi Diagnostics
Vysis and Eos Join Forces to Identify New Markers of Breast Cancer
Cytogen and Progenics Announce Joint Venture to Collaborate on Prostate
Cancer Immunotherapeutics
Pharmacia & Upjohn Announces Agreement With Sensus Drug Development
Corporation
OXiGENE and Active Biotech Enter Research Collaboration to Develop
Anti-Inflammatory Therapeutics
Invitrogen Corporation and NOVEX Sign Definitive Agreement to Merge
Aurora Biosciences Announces Issuance of First U.S. Patent For NanoWell
Assay Plate
Celltech plc merger with Chiroscience Group plc
SEC Registration Filed for Genentech Public Offering
Abbott Laboratories Declares 302nd Consecutive Quarterly Dividend
Chevron Chemical Co. Sells Part of Specialty Polymers Business
Academic Researchers and Industry Associations Agree Reports on Bt Crop
Impact on Monarch Butterflies Overblown
Biogen Announces 2-for-1 Stock Split
Genomics Partnership between Organon & Incyte Extended
Isco Reports Third Quarter Fiscal 1999 Results
BioChem Pharma Announces Agreement in Principle to Purchase 8 Million
BioChem Common Shares from Glaxo Wellcome Inc.
Amersham Pharmacia Biotech Signs Two Major Mass Spec/Proteomics Deals
